Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.
Explore this paper's citation graph
Summary
This study evaluated the susceptibility of Escherichia coli to quinolones in 72 stool samples collected from 31 patients with solid tumours who had undergone high dose chemotherapy and peripheral blood stem-cell rescue with ciprofloxacin prophylaxis.
- Type
- article
- Published
- 1999-07-01
- Cited by
- 30
- References
- 10
- Access
- Open access
- OpenAlex
- https://openalex.org/W2142663711
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22856383
Keywords
Ciprofloxacin, Incidence (geometry), Medicine, Chemotherapy, Escherichia coli
References
- National Committee for Clinical Laboratory Standards.
- Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies.
- Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
- Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.
- Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.
- Antimicrobial Prophylaxis in Bone Marrow Transplantation
- Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.
- Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis
- [The prevalence of Escherichia coli susceptibility to quinolones and other antibiotics in community-acquired bacteriurias in Madrid].
- Blood and marrow transplantation activity in Europe 1995
Cited by
- Approach to the complications of treatment for acute leukemia in the elderly.
- Point: fluoroquinolone-based antibacterial chemoprophylaxis in neutropenic cancer patients works for defined outcomes in defined populations, but must be used wisely.
- Impact of Antibiotic Use during Hospitalization on the Development of Gastrointestinal Colonization with Escherichia coli with Reduced Fluoroquinolone Susceptibility
- Re: long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms.
- Infectious morbidity in critically ill patients with cancer.
- Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
- Relapsing bloodstream infections during treatment of acute leukemia
- Fluoroquinolone prophylaxis against febrile neutropenia in areas with high fluoroquinolone resistance--an Asian perspective.
- Fluoroquinolone-resistant Escherichia coli Carriage in Long-Term Care Facility
- Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia
- Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
- Prevalence and Risk Factors for Selection of Quinolone-Resistant Escherichia coli Strains in Fecal Flora of Patients Receiving Quinolone Therapy
- Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.
- Natural History of Colonization with Gram-Negative Multidrug-Resistant Organisms among Hospitalized Patients
- Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coliin Taiwan and Contributions of Distinct Selective Pressures
- Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
- Duration of Outpatient Fecal Colonization Due to Escherichia coli Isolates with Decreased Susceptibility to Fluoroquinolones: Longitudinal Study of Patients Recently Discharged from the Hospital
- Comparison of Escherichia coli and Klebsiella pneumoniae Liver Abscesses
- Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora.
- Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.
Related papers
- Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella typhi.
- Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
- Inhibitory Effect Comparison of Sanhuang and Ciprofloxacin against E.coli in vitro
- Studies on the minimum inhibitory concentration of six kinds of fluoroquinolones to Salmonella
- Antibacterial Activity of Combination of Ciprofloxacin and Colistin against Isolated E. coli from Pigs
- Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
- Comparison of Antibacterial Activity of Ciprofloxacin in Vitro under Different pH Conditions
- Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
- Study on the susceptibility of Enterococcus faecalis from infectious processes to ciprofloxacin and vancomycin
- High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.